Skip to main content
Loading

AVM Biotechnology, Inc

October 18, 2023
Franciscan C
Oncology
Mobilizing endogenous bi-specific Natural-Killer T-like cells that penetrate solid tumors and blood cancers
Speakers
Theresa Deisher - AVM Biotechnology, Inc